Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: JACC Cardiovasc Imaging. 2013 May 1;6(8):877–885. doi: 10.1016/j.jcmg.2012.11.017

Figure 4.

Figure 4

Figure 4

Changes in left ventricular ejection fraction (LVEF; y-axis; panel A) and pulse wave velocity (PWV; y-axis; panel B) versus the cumulative doses of doxorubicin equivalent (x-axes; panels A and B). Each symbol represents data from a participant, and the regression line and equations are shown for each panel. No association between changes in LVEF or PWV and the doses of doxorubicin equivalent chemotherapy were observed.

HHS Vulnerability Disclosure